Benito León, Julián Bermejo Pareja, Félix Guijarro Castro, Cristina
Widespread urticaria due to intramuscular interferon beta-1a therapy for multiple sclerosis [artículo] - Neurological Sciences, 2011 - 32(2):309-311.
Formato Vancouver:
Guijarro C, Benito-León J, Bermejo-Pareja F. Widespread urticaria due to intramuscular interferon beta-1a therapy for multiple sclerosis. Neurol Sci. 2011 Apr;32(2):309-11.
PMID:20890624
Contiene 9 referencias
We describe two multiple sclerosis patients who displayed widespread urticaria due to intramuscular interferon beta-1a (INF-beta-1a). Clinicians should be aware of this adverse event, since it may be severe and it may lead to the definitive interruption of treatment. Widespread urticaria complicating intramuscular INF-beta-1a therapy in multiple sclerosis should be therefore added to the list of dermatological lesions associated with interferon therapy.
Widespread urticaria due to intramuscular interferon beta-1a therapy for multiple sclerosis [artículo] - Neurological Sciences, 2011 - 32(2):309-311.
Formato Vancouver:
Guijarro C, Benito-León J, Bermejo-Pareja F. Widespread urticaria due to intramuscular interferon beta-1a therapy for multiple sclerosis. Neurol Sci. 2011 Apr;32(2):309-11.
PMID:20890624
Contiene 9 referencias
We describe two multiple sclerosis patients who displayed widespread urticaria due to intramuscular interferon beta-1a (INF-beta-1a). Clinicians should be aware of this adverse event, since it may be severe and it may lead to the definitive interruption of treatment. Widespread urticaria complicating intramuscular INF-beta-1a therapy in multiple sclerosis should be therefore added to the list of dermatological lesions associated with interferon therapy.
